|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00696527 |
|
Date of registration:
|
10/06/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
National Survey on Infiltrative Breast Cancer
CSI |
|
Scientific title:
|
National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer |
|
Date of first enrolment:
|
June 2007 |
|
Target sample size:
|
1500 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00696527 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Alain Castaigne, Medical Director |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
AstraZeneca |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Women> or = 18 years old
- Women with newly diagnosis of infiltrative breast cancer
- Agree to take part in this study
Exclusion Criteria:
- Women with other malignant tumor (except in situ cervical carcinoma or treated basal
cell carcinoma)
- Women with in situ ductal carcinoma or in situ lobular carcinoma
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Infiltrative Breast Cancer
|
|
Primary Outcome(s)
|
|
Radiological, Clinical and Histological characteristics
[Time Frame: Once]
|
|
Secondary Outcome(s)
|
|
Treatments: Surgery, radiotherapy, chemotherapy, hormonotherapy.
[Time Frame: Once]
|
|
Secondary ID(s)
|
|
NIS-OFR-DUM-2007/1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|